ARH-46023

N/A

Report date: 2023/02/12 00:15:29

Base Information

Drug NameARH-46023
Drug Alias NameARVitamab™ARH-460-23H-460-23
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArius Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArius Research Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A